Literature DB >> 11019978

Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells.

E Bretschneider1, M Braun, A Fischer, M Wittpoth, E Glusa, K Schrör.   

Abstract

This study investigates the mitogenic effect of the coagulation factor Xa in smooth muscle cells (SMC) from human saphenous vein and the procoagulant activity of these cells. Factor Xa elicited a concentration-dependent increase in [3H]thymidine incorporation. This mitogenic effect of factor Xa was inhibited by DX-9065a and BABCH, indicating the requirement of proteolytic activity of the enzyme. Factor Xa activated the MAP kinases ERK1/2 concentration- and time-dependently. PDGF-neutralizing antibodies neither inhibited the increase in [3H]thymidine incorporation nor ERK-1/2 phosphorylation in factor Xa-stimulated cells, suggesting that factor Xa-induced signaling and mitogenic activity in human venous SMC are independent of PDGF. Exposure of SMC to recalcified plasma resulted in a significant thrombin generation which was inhibited by anti-tissue factor antibody, tissue factor pathway inhibitor, inactivated factor VIIa and DX-9065a. These data indicate that interaction of SMC with the clotting system may contribute to venous graft disease, i.e. thrombus formation and intimal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11019978

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Factor Xa-A pleuripotential protease.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

Review 2.  The importance of factor Xa regulatory pathways in vascular thromboresistance: focus on protein Z.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

Review 3.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

4.  Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1/JNK/AP-1 pathway.

Authors:  Wen-chin Ko; Bing-chang Chen; Ming-jen Hsu; Chia-ti Tsai; Chuang-ye Hong; Chien-huang Lin
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

5.  Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells.

Authors:  E Bretschneider; R Kaufmann; M Braun; G Nowak; E Glusa; K Schrör
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 6.  Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.

Authors:  Akihito Muto; Lynn Model; Kenneth Ziegler; Sammy D D Eghbalieh; Alan Dardik
Journal:  Circ J       Date:  2010-07-01       Impact factor: 2.993

Review 7.  The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.

Authors:  Keren Borensztajn; Jan H von der Thüsen; Maikel P Peppelenbosch; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2009-11-28       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.